Company News

Share this article:

Microsoft acquired certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics, the latter a wholly owned subsidiary of Merck. The deal bolsters Microsoft's Amalga Life Sciences platform by integrating genetic, genomic, metabolomic and proteomics data management into the platform. Microsoft furthered partnered with Merck to enhance the Amalga Life Sciences platform to “meet emerging pharmaceutical research needs,” according to a statement.

 

Merge Healthcare, a health IT solutions provider, will acquire etrials Worldwide, a clinical trials software and services company. The combined organization will provide clinical trial sponsors and contract research organizations with solutions that include both critical imaging technologies and eClinical capabilities, according to a statement.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.